Keyphrases
Central Nervous System
100%
Toxoplasma Gondii Infection
100%
Interferon-α (IFN-α)
66%
Immune Response
66%
Toxoplasmosis
66%
Infection Control
66%
Toxoplasma Gondii (T. gondii)
33%
High Mortality
33%
Inflammation
33%
Healthy Individuals
33%
Acute Disease
33%
Age of Infection
33%
Acute Phase
33%
Opportunistic Infections
33%
Infection Reactivation
33%
Muscle Cells
33%
Unique Mechanism
33%
Immune Privilege
33%
Response Control
33%
Laboratory Mice
33%
Effector Proteins
33%
Human Toxoplasmosis
33%
Mild Disease
33%
Disease Symptoms
33%
Zoonotic Infections
33%
Damage Potential
33%
Limiting Potential
33%
Immune Clearance
33%
Dormant Cyst
33%
Immunology and Microbiology
Toxoplasmosis
100%
Central Nervous System
100%
interferon
50%
Immune Response
50%
Toxoplasma gondii
25%
Muscle Cell
25%
Immune Privilege
25%
Opportunistic Infection
25%
Immune Escape
25%
Experimental Mouse
25%
Zoonotic
25%